Literature DB >> 19075396

TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4.

Toshihiro Ito1, Matthew Schaller, Cory M Hogaboam, Theodore J Standiford, Matyas Sandor, Nicholas W Lukacs, Stephen W Chensue, Steven L Kunkel.   

Abstract

TLR9 activation is important for the maintenance of mycobacteria-elicited pulmonary granulomatous responses, hallmarks of protective immune responses following mycobacterial infection. However, the mechanism or mechanisms underlying this effect of TLR9 are not clear. Here, we show that Tlr9-deficient mice challenged with a Mycobacterium antigen display an altered Th17 cytokine profile, decreased accumulation of granuloma-associated myeloid DCs, and profoundly impaired delta-like 4 (dll4) Notch ligand expression. Mechanistic analysis revealed that WT bone marrow-derived DCs but not macrophages promoted the differentiation of Th17 cells from bacillus Calmette-Guérin-challenged (BCG-challenged) lung CD4+ T cells. Both lung and bone marrow DCs isolated from Tlr9-deficient mice inoculated with Mycobacterium antigen expressed lower levels of dll4 Notch ligand than the same cells isolated from WT mice. Passively immunizing WT mice with neutralizing antibodies specific for dll4 during granuloma formation resulted in larger granulomas and lower levels of Th17-related cytokines. In addition, dll4 specifically regulated Th17 activation in vitro. Together, these results suggest dll4 plays an important role in promoting Th17 effector activity during a mycobacterial challenge. Furthermore, TLR9 seems to be required for optimal dll4 expression and the regulation of Mycobacterium antigen-elicited granuloma formation in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075396      PMCID: PMC2613456          DOI: 10.1172/JCI35647

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Chemokines in immunity.

Authors:  O Yoshie; T Imai; H Nomiyama
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

Review 3.  Mammalian Toll-like receptors.

Authors:  Shizuo Akira
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

4.  Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present.

Authors:  Andrea M Cooper; Andre Kipnis; Joanne Turner; Jeanne Magram; Jessica Ferrante; Ian M Orme
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

Review 6.  Regulation of macrophage-derived chemokine (MDC, CCL22) production.

Authors:  Uki Yamashita; Etsushi Kuroda
Journal:  Crit Rev Immunol       Date:  2002       Impact factor: 2.214

7.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

8.  A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone-marrow-derived macrophages to Toll-like receptor agonists.

Authors:  Amrita D Joshi; Tracy Raymond; Ana L Coelho; Steven L Kunkel; Cory M Hogaboam
Journal:  J Leukoc Biol       Date:  2007-11-20       Impact factor: 4.962

9.  Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.

Authors:  Brian Abel; Nathalie Thieblemont; Valerie J F Quesniaux; Najmeeyah Brown; Joseph Mpagi; Kensuke Miyake; Franck Bihl; Bernhard Ryffel
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

View more
  54 in total

1.  MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function.

Authors:  Ryoko Shimizu-Hirota; Wanfen Xiong; B Timothy Baxter; Steven L Kunkel; Ivan Maillard; Xiao-Wei Chen; Farideh Sabeh; Rui Liu; Xiao-Yan Li; Stephen J Weiss
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

Review 2.  Notch system in the linkage of innate and adaptive immunity.

Authors:  Toshihiro Ito; Judith M Connett; Steven L Kunkel; Akihiro Matsukawa
Journal:  J Leukoc Biol       Date:  2012-03-29       Impact factor: 4.962

Review 3.  DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses.

Authors:  Lijun Meng; Shaoyan Hu; Jian Wang; Shan He; Yi Zhang
Journal:  Pharmacol Res       Date:  2016-09-14       Impact factor: 7.658

4.  Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development.

Authors:  Ribal Bassil; Bing Zhu; Youmna Lahoud; Leonardo V Riella; Hideo Yagita; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

5.  Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury.

Authors:  Nicholas A Dewyer; Osama M El-Sayed; Catherine E Luke; Megan Elfline; Nicolai Kittan; Ron Allen; Adriana Laser; Carson Oostra; Anthony Comerota; Cory Hogaboam; Steven L Kunkel; Peter K Henke
Journal:  Thromb Haemost       Date:  2015-07-16       Impact factor: 5.249

Review 6.  Toll like receptors in diseases of the lung.

Authors:  Melissa A Kovach; Theodore J Standiford
Journal:  Int Immunopharmacol       Date:  2011-05-30       Impact factor: 4.932

Review 7.  Notch signaling pathway in infectious diseases: role in the regulation of immune response.

Authors:  Ricardo Cardoso Castro; Relber Aguiar Gonçales; Fabiana Albani Zambuzi; Fabiani Gai Frantz
Journal:  Inflamm Res       Date:  2021-02-09       Impact factor: 4.575

Review 8.  Impact of notch signaling on inflammatory responses in cardiovascular disorders.

Authors:  Thibaut Quillard; Beatrice Charreau
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

9.  Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia.

Authors:  Urvashi Bhan; Megan N Ballinger; Xianying Zeng; Michael J Newstead; Matthew D Cornicelli; Theodore J Standiford
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

10.  Delta-like 4 differentially regulates murine CD4 T cell expansion via BMI1.

Authors:  Matthew A Schaller; Hannah Logue; Sumanta Mukherjee; Dennis M Lindell; Ana Lucia Coelho; Pamela Lincoln; William F Carson; Toshihiro Ito; Karen A Cavassani; Stephen W Chensue; Cory M Hogaboam; Nicholas W Lukacs; Steven L Kunkel
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.